GRAIL, Inc. (GRAL)
79.56
-2.98
(-3.62%)
USD |
NASDAQ |
Aug 26, 16:00
79.56
0.00 (0.00%)
After-Hours: 17:37
GRAIL 1 Year Total Returns (Daily) : 150.7% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | 150.7% |
| August 24, 2026 | 123.7% |
| August 21, 2026 | 139.9% |
| August 20, 2026 | 142.4% |
| August 19, 2026 | 135.4% |
| August 18, 2026 | 116.1% |
| August 17, 2026 | 115.7% |
| August 14, 2026 | 110.9% |
| August 13, 2026 | 100.8% |
| August 12, 2026 | 105.2% |
| August 11, 2026 | 130.9% |
| August 10, 2026 | 128.0% |
| August 07, 2026 | 110.8% |
| August 06, 2026 | 91.66% |
| August 05, 2026 | 119.8% |
| August 04, 2026 | 118.8% |
| August 03, 2026 | 114.3% |
| July 31, 2026 | 100.4% |
| July 30, 2026 | 110.7% |
| July 29, 2026 | 85.93% |
| July 28, 2026 | 68.33% |
| July 27, 2026 | 65.72% |
| July 24, 2026 | 70.80% |
| July 23, 2026 | 72.11% |
| July 22, 2026 | 90.15% |
| Date | Value |
|---|---|
| July 21, 2026 | 111.7% |
| July 20, 2026 | 95.82% |
| July 17, 2026 | 102.2% |
| July 16, 2026 | 96.56% |
| July 15, 2026 | 92.99% |
| July 14, 2026 | 81.98% |
| July 13, 2026 | 76.28% |
| July 10, 2026 | 65.94% |
| July 09, 2026 | 79.90% |
| July 08, 2026 | 63.73% |
| July 07, 2026 | 53.38% |
| July 06, 2026 | 47.58% |
| July 02, 2026 | 45.31% |
| July 01, 2026 | 38.35% |
| June 30, 2026 | 32.77% |
| June 29, 2026 | 41.33% |
| June 26, 2026 | 33.50% |
| June 25, 2026 | 44.17% |
| June 24, 2026 | 46.94% |
| June 23, 2026 | 41.89% |
| June 22, 2026 | 36.09% |
| June 18, 2026 | 31.59% |
| June 17, 2026 | 41.38% |
| June 16, 2026 | 37.09% |
| June 15, 2026 | 44.78% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 329.2% |
| Oncolytics Biotech, Inc. | -12.88% |
| Sangamo Therapeutics, Inc. | -72.93% |
| Sarepta Therapeutics, Inc. | 4.76% |
| Anixa Biosciences, Inc. | 22.00% |